🇺🇸 FDA
Company

Arbutus

Arbutus Biopharma Corp

ABUS biotech USA

Quick answer

Arbutus is a biotech company (ABUS) headquartered in WARMINSTER, PA, USA with 11 tracked pipeline programs.

Pipeline (11)

project

AB-729

Chronic Hepatitis b

Phase 2 · small_molecule · completed

1 trials project

ARB-001467

Hepatitis B, Chronic

Phase 2 · small_molecule · completed

1 trials project

Imdusiran

Hepatitis B, Chronic

Phase 2 · small_molecule · terminated

1 trials project

Imdusiran (AB-729)

Chronic Hepatitis B

Phase 2 · small_molecule · active

1 trials project

TKM-080301

Cancer

Phase 2 · small_molecule · completed

1 trials project

TKM-080301

Hepatocellular Carcinoma

Phase 2 · small_molecule · completed

1 trials project

AB-101

Chronic Hepatitis b

Phase 1 · small_molecule · completed

1 trials project

AB-836

Chronic Hepatitis

Phase 1 · small_molecule · terminated

1 trials project

PRO-040201

Hypercholesterolemia

Phase 1 · small_molecule · terminated

1 trials project

TKM-100201

Ebola Virus Infection

Phase 1 · small_molecule · terminated

1 trials project

TKM-100802 for Injection

Ebola Virus Infection

Phase 1 · small_molecule · terminated

1 trials

Patents (8)

patent

US 12357705

Negatively charged peg-lipid conjugates

Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12350383

Cationic lipids containing silicon

Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12251470

Lipid nanoparticle formulations

Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12129467

Non-liposomal systems for nucleic acid delivery

Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12083118

Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same

Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12043833

Targeted compositions

Expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12042541

Lipids and compositions for the delivery of therapeutics

Expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12023383

Lipid compositions

Expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)